Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
259 studies found for:    "Diabetic Nephropathies"
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetic Nephropathies"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 Middle;   Drug: MT-3995 High;   Drug: Placebo
2 Completed Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995-Low;   Drug: MT-3995-High;   Drug: Placebo
3 Completed Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995;   Drug: Placebo
4 Completed The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
5 Completed Spironolactone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Spironolactone
6 Terminated Effect of Sulodexide in Overt Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Sulodexide
7 Completed Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)
Condition: Diabetic Nephropathy
Intervention: Other: Multifactorial Intervention
8 Completed Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Behavioral: DiaNe consultation and support program
9 Completed A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
10 Completed A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995 Low;   Drug: MT-3995 High;   Drug: Placebo
11 Recruiting Resveratrol's Effects in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Resveratrol;   Drug: Placebo;   Drug: Losartan
12 Unknown  Colchicine for Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: colchicine
13 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
14 Completed Effect of Pyridorin in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Pyridorin (pyridoxamine dihydrochloride)
15 Completed Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: placebo;   Drug: Milk Thistle extract
16 Completed Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Sevelamer Carbonate;   Drug: Calcium Carbonate
17 Completed Benfotiamine in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Benfotiamine;   Drug: Placebo
18 Unknown  Aldosterone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Spironolactone;   Drug: Placebo
19 Completed Effects of PH3 in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: PH3
20 Not yet recruiting Colchicine for Diabetic Nephropathy Trial
Condition: Diabetic Nephropathies
Interventions: Drug: Colchicine;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.